THE FEATURES OF THE COURSE OF HEPATITIS B IN HIV-INFECTED INDIVIDUALSS AND ITS TREATMENT

Authors

  • V. D. Moskaliuk Bukovynian State Mediсal University
  • I. V. Rudan Bukovynian State Mediсal University
  • V. D. Sorokhan Bukovynian State Mediсal University

DOI:

https://doi.org/10.11603/1681-2727.2018.3.9422

Keywords:

HBV infection, HIV infection, combined infection, features of the course, treatment

Abstract

The purpose of the study - based on the analysis of literary information to highlight the features of the course of hepatitis B in HIV-infected individuals, as well as the basic principles of treatment of these patients and drugs that used for these purpose in the world and in Ukraine.

HIV and parenteral viral hepatitis belong to socially significant diseases that can significantly affect the demographic situation in the country. Ukraine belongs to countries with an average prevalence of HBV, but there is no data on the frequency of detecting HBV markers in patients with HIV.

From the published data of several studies, the mutual influence of HIV and HBV on the course of both HIV infection and chronic hepatitis B (CHBV) is known. The incidence of AIDS and AIDS-related deaths is significantly higher in people with combined HBV / HIV infection, which is now a global public health problem.

The basic principles of treatment for patients with CHBV / HIV are consistent with those in patients with HBV-monoinfection. According to the published results of several epidemiological studies, the main factor leading to chronic HCV is the level of HBV DNA in patients’ blood or viral load. Therefore, the goal of treatment is to suppress HBV replication to reduce inflammation and to stop or slow down the progression of fibrosis, thereby preventing the late complications of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). All these patients should receive antiretroviral therapy (ART), regardless of the number of CD4 + lymphocytes.

According to published results of a number of studies, the terminal stage of liver disease is a frequent cause of hospitalization and death of patients with combined HBV / HIV infection. But there are still controversial therapies for people with combined HIV and parenteral viral hepatitis. Therefore, the choice of optimal tactics for the management of these patients and the timely appointment of adequate treatment remains relevant.

Author Biographies

V. D. Moskaliuk, Bukovynian State Mediсal University

professor of the Department of internal medicine and infectious diseases, Higher state educational establishment of Ukraine «Bukovinian State Mediсal University»

I. V. Rudan, Bukovynian State Mediсal University

assistant of the Department of internal medicine and infectious diseases, Higher state educational establishment of Ukraine «Bukovinian State Mediсal University»

V. D. Sorokhan, Bukovynian State Mediсal University

associate professor of the Department of internal medicine and infectious diseases, Higher state educational establishment of Ukraine «Bukovinian State Mediсal University»

Published

2018-10-12

How to Cite

Moskaliuk, V. D., Rudan, I. V., & Sorokhan, V. D. (2018). THE FEATURES OF THE COURSE OF HEPATITIS B IN HIV-INFECTED INDIVIDUALSS AND ITS TREATMENT. Infectious Diseases – Infektsiyni Khvoroby, (3), 42–54. https://doi.org/10.11603/1681-2727.2018.3.9422

Issue

Section

Reviews and lectures